BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 2009
View Archived Issues
Route of administration affects immunoglobulin use in immunodeficiency patients
Read More
Prostate cancer patients' survival predicted by radiologic progression improves with new vaccine
Read More
Novel b-Raf inhibitors claimed by Takeda
Read More
Statin-induced atherosclerotic plaque regression is more effective in women than men
Read More
Shanghai Hengrui discloses dipeptidyl peptidase IV inhibitors for diabetes
Read More
New heat shock protein 90 inhibitors investigated for effects in Alzheimer's disease
Read More
Synairgen reports preliminary findings from phase I trial of IFN-beta biomarker neopterin
Read More
First patient treated in Osiris' phase II stem cell trial for myocardial infarction
Read More
Intercell's Ixiaro approved in Europe to prevent Japanese encephalitis
Read More
Micromet receives milestone payment from Nycomed for MT-203
Read More
Gilead's phase III darusentan study for hypertension meets primary endpoints
Read More
Phase III results reported for Labopharm's twice-daily tramadol/acetaminophen combination
Read More
CV Technologies changes name to Afexa Life Sciences as part of rebranding plan
Read More
StemCells acquires Stem Cell Sciences
Read More
Enrollment completed in Depomed's phase III trial of Serada in menopausal hot flashes
Read More
Pfizer discontinues one of its phase III trials of Sutent in advanced breast cancer
Read More
InSite Vision and Nitten sign international licensing and distribution agreement for AzaSite
Read More
Novel Raf kinase inhibitors presented by GlaxoSmithKline
Read More
Orchid Research Laboratories presents novel monoamine oxidase inhibitors
Read More
Novel bile acid responsive receptor ligands discovered by Kalypsus
Read More
Novel mu-opioid receptor ligands developed by OSI Prosidion for the treatment of obesity
Read More
Low-molecular-weight allosteric inhibitor of luteinizing hormone receptor identified
Read More
Priligy reaches first market
Read More
Alnylam initiates phase I ALN-VSP trial in patients with liver cancer
Read More
FDA grants priority review for Genmab's Arzerra
Read More